Biotechnology, Investing, Venture Capital, Science, Chemistry.
and imaging dyes is leading to new ways to measure protein motion and discover new drugs for previously undruggable or hard-to-drug targets. Eikon Therapeutics, founded by Betzig and Robert Tjian, has taken the lead to commercialize super-resolution microscopy for drug discovery with the thesis